Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
Paycom Software (PAYC) shares advanced as KeyBanc upgraded the stock and raised the price target on optimism about sales, ...
Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...